Sarah Warren

Nanostring Technologies (United States) — United States

Medicine · Health Sciences

40h-index13.5kcitations289works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(110), Immunotherapy and Immune Responses(43), CAR-T cell therapy research(33), HER2/EGFR in Cancer Research(32), Single-cell and spatial transcriptomics(30)

Publications285 total

Scalable prediction of symmetric protein complex structures
2025
Integrating 12 Spatial and Single Cell Technologies to Characterise Tumour Neighbourhoods and Cellular Interactions in three Skin Cancer Types
2025· 1 citedOpen Access
A single-nucleus and spatial transcriptomic atlas of the COVID-19 liver reveals topological, functional, and regenerative organ disruption in patients
Genome biology·2025· 6 citedOpen Access
Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials
UNC Libraries·2025Open Access
1172 Gene signatures predict immune-related skin adverse events in melanoma patients
Regular and Young Investigator Award Abstracts·2024Open Access
Abstract PS03-03: The spatially resolved single-cell atlas of the tumor immune architecture revealed the central role of IFN-alpha and plasmacytoid dendritic cells in triple-negative breast cancer in the Mayo Clinic cohort and FinXX trial
Cancer Research·2024
Molecular Pathology
Journal of Translational Medicine·2024Open Access
1247 Gene signature predict autoimmune toxicity in patients with metastatic melanoma
Regular and Young Investigator Award Abstracts·2023Open Access
41 CD39 affect the prognostic role of NLR via N2 neutrophils in metastatic melanoma patients treated with immunotherapy
Regular and Young Investigator Award Abstracts·2023Open Access
‘You drew my tears’: attunement in making response art alongside the client
International Journal of Art Therapy·2023· 2 cited
Translational and clinical applications of the GeoMx digital spatial profiling platform
Diagnostic Molecular Pathology·2023
Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2
Cell Reports·2023· 3 citedOpen Access
1163P CD39 affect the prognostic role of NLR via N2 neutrophils in metastatic melanoma patients treated with immunotherapy
Annals of Oncology·2023Open Access
Building smart CAR T cell therapies: The path to overcome current challenges
Cancer Cell·2023· 13 cited
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Journal of Translational Medicine·2023· 32 citedOpen Access
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
2023· 2 citedOpen Access
Characteristics associated with spatially resolved immune landscapes in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.
Journal of Clinical Oncology·2023
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer
Nature Communications·2023· 40 citedOpen Access
Figure S2 from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer
2023Open Access
Supplement from Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer
2023Open Access
page 1 of 15Next →

Frequent Co-authors

Patrick Danaher(11), Alessandra Cesano(10), Edward A. Miao(9), Joseph Beechem(9), S. Church(8), Jason Reeves(8), Alan Aderem(7), Dat P. Mao(5), Yan Liang(5), Tyler Hether(5), Leonard D’Amico(5), Mary L. Disis(5), Steven P. Fling(5), Daniel R. Zollinger(4), SuFey Ong(4), Jonathan Chen(4), Christopher J. Pinto(4), Erroll H. Rueckert(4), Nir Hacohen(4), Dejan Juric(4)